Therefore, it may be possible to target senescent cells by engineering T cells expressing NKG2D-CAR (NKG2D-CAR-T cells) that recognize NKG2D ligands on the surface of senescent cells based on cancer research [159]. The gene discussed is KLRK1; the disease is cancer.